Improving survival in pulmonary arterial hypertension

被引：7

作者：

Humbert, M ^{[1
]}

机构：

[1] Hop Antoine Beclere, Serv Pneumol, F-92140 Clamart, France

来源：

EUROPEAN RESPIRATORY JOURNAL | 2005年 / 25卷 / 02期

关键词：

D O I：

10.1183/09031936.05.00129604

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：218 / 220

页数：3

共 24 条

[1] Medical therapy for pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines [J].

Badesch, DB ;

Abman, SH ;

Ahearn, GS ;

Barst, RJ ;

McCrory, DC ;

Simonneau, G ;

McLaughlin, VV .

CHEST, 2004, 126 (01) :35S-62S

[2] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].

Barst, RJ ;

Rubin, LJ ;

Long, WA ;

McGoon, MD ;

Rich, S ;

Badesch, DB ;

Groves, BM ;

Tapson, VF ;

Bourge, RC ;

Brundage, BH ;

Koerner, SK ;

Langleben, D ;

Keller, CA ;

Murali, S ;

Uretsky, BF ;

Clayton, LM ;

Jobsis, MM ;

Blackburn, SD ;

Shortino, D ;

Crow, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301

[3] Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study [J].

Channick, RN ;

Simonneau, G ;

Sitbon, O ;

Robbins, IM ;

Frost, A ;

Tapson, VF ;

Badesch, DB ;

Roux, S ;

Rainisio, M ;

Bodin, F ;

Rubin, LJ .

LANCET, 2001, 358 (9288) :1119-1123

[4] SURVIVAL IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION - RESULTS FROM A NATIONAL PROSPECTIVE REGISTRY [J].

DALONZO, GE ;

BARST, RJ ;

AYRES, SM ;

BERGOFSKY, EH ;

BRUNDAGE, BH ;

DETRE, KM ;

FISHMAN, AP ;

GOLDRING, RM ;

GROVES, BM ;

KERNIS, JT ;

LEVY, PS ;

PIETRA, GG ;

REID, LM ;

REEVES, JT ;

RICH, S ;

VREIM, CE ;

WILLIAMS, GW ;

WU, M .

ANNALS OF INTERNAL MEDICINE, 1991, 115 (05) :343-349

[5] PRIMARY PULMONARY HYPERTENSION .1. CLINICAL AND HEMODYNAMIC STUDY [J].

DRESDALE, DT ;

SCHULTZ, M ;

MICHTOM, RJ .

AMERICAN JOURNAL OF MEDICINE, 1951, 11 (06) :686-705

[6] The new clinical trials on pharmacological treatment in pulmonary arterial hypertension [J].

Galiè, N ;

Manes, A ;

Branzi, A .

EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (04) :1037-1049

[7] Combination therapy for pulmonary arterial hypertension: still more questions than answers [J].

Hoeper, MM ;

Dinh-Xuan, AT .

EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (03) :339-340

[8] Combination of bosentan with epoprostenol in pulmonary arterial hypertension:: BREATHE-2 [J].

Humbert, M ;

Barst, RJ ;

Robbins, IM ;

Channick, RN ;

Galié, N ;

Boonstra, A ;

Rubin, LJ ;

Horn, EM ;

Manes, A ;

Simonneau, G .

EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (03) :353-359

[9] Cellular and molecular pathobiology of pulmonary arterial hypertension [J].

Humbert, M ;

Morrell, NW ;

Archer, SL ;

Stenmark, KR ;

MacLean, MR ;

Lang, IM ;

Christman, BW ;

Weir, EK ;

Eickelberg, O ;

Voelkel, NF ;

Rabinovitch, M .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :13S-24S

[10] Drug therapy: Treatment of pulmonary arterial hypertension [J].

Humbert, M ;

Sitbon, O ;

Simonneau, G .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (14) :1425-1436

← 1 2 3 →